MUMBAI, India, July 11 -- Intellectual Property India has published a patent application (202541060120 A) filed by Saveetha Institute Of Medical And Technical Sciences, Chennai, Tamil Nadu, on June 24, for 'micro-fluidic assisted biohybrid polymer encapsulation technology for release of bioactives against respiratory syncytial virus (rsv).'
Inventor(s) include Vanitha M; Ajay Guru; and Deepak Nallaswamy Veeraiyan.
The application for the patent was published on July 11, under issue no. 28/2025.
According to the abstract released by the Intellectual Property India: "This invention presents a novel microfluidic-assisted biohybrid polymer encapsulation technology for the controlled release of antiviral bioactives targeting respiratory syncytial virus (RSV). The system integrates rhamnolipid-alginate matrices with microfluidics to produce uniform capsules that release bioactives in response to environmental triggers, such as pH changes and enzymatic activity. The encapsulation process leverages a double-emulsion microfluidic setup to generate monodisperse capsules with precise control over size and release kinetics. This technology enhances therapeutic outcomes by providing localized delivery, reducing systemic toxicity, and improving bioactive stability. The invention IS scalable, allowing for high-throughput production suitable for inhalable formulations. It offers a transformative approach to RSV treatment by combining antiviral efficacy with controlled release mechanisms, positioning it as a versatile platform for pulmonary drug delivery against respiratory pathogens."
Disclaimer: Curated by HT Syndication.
